Using machine learning to improve living.
A groundbreaking machine-learning study has revealed the optimal drug combinations to prevent the recurrence of COVID-19 after initial infection. Interestingly, the ideal combination differs among patients.
Using real-world data from a hospital in China, the UC Riverside-led study discovered that factors such as age, weight, and other health conditions dictate which drug combinations most effectively reduce recurrence rates. This finding has been published in the journal Frontiers in Artificial Intelligence.
That the data came from China is significant for two reasons. First, when patients are treated for COVID-19 in the U.S., it is normally with one or two drugs. Early in the pandemic, doctors in China could prescribe as many as eight different drugs, enabling analysis of more drug combinations. Second, COVID-19 patients in China must quarantine in a government-run hotel after being discharged from the hospital, which allows researchers to learn about reinfection rates in a more systematic way.
The study project began in April 2020, about a month into the pandemic. At the time, most studies were focused on death rates. However, doctors in Shenzhen, near Hong Kong, were more concerned about recurrence rates because fewer people there were dying.
“Surprisingly, nearly 30% of patients became positive again within 28 days of being released from the hospital,” said Jiayu Liao, associate professor of bioengineering and study co-author.
Data for more than 400 COVID patients was included in the study. Their average age was 45, most were infected with moderate cases of the virus, and the group was evenly divided by gender. Most were treated with one of various combinations of an antiviral, an anti-inflammatory, and an immune-modulating drug, such as interferon or hydroxychloroquine.
That various demographic groups had better success with different combinations can be traced to the way the virus operates.
“COVID-19 suppresses interferon, a protein cells make to inhibit invading viruses. With defenses lowered, COVID can replicate until the immune system explodes in the body, and destroys tissues,” explained Liao.
People who had weaker immune systems prior to COVID infection required an immune-boosting drug to fight the infection effectively. Younger peoples’ immune systems become overactive with infection, which can lead to excessive tissue inflammation and even death. To prevent this, younger people require an immune suppressant as part of their treatment.
“When we get treatment for diseases, many doctors tend to offer one solution for people 18 and up. We should now reconsider age differences, as well as other disease conditions, such as diabetes and obesity,” Liao said.
Most of the time, when conducting drug efficacy tests, scientists design a clinical trial in which people having the same disease and baseline characteristics are randomly assigned to either treatment or control groups. But that approach does not consider other medical conditions that may affect how the drug works — or doesn’t work — for specific sub-groups.
Because this study utilized real-world data, the researchers had to adjust for factors that could affect the outcomes they observed. For example, if a certain drug combination was given mostly to older people and proved ineffective, it would not be clear whether the drug is to blame or the person’s age.
“For this study, we pioneered a technique to attack the challenge of confounding factors by virtually matching people with similar characteristics who were undergoing different treatment combinations,” Cui said. “In this way, we could generalize the efficacy of treatment combinations in different subgroups.”
While COVID-19 is better understood today, and vaccines have greatly reduced death rates, there remains much to be learned about treatments and preventing reinfections. “Now that recurrence is more of a concern, I hope people can use these results,” Cui said.
Machine learning has been used in many areas related to COVID, such as disease diagnosis, vaccine development, and drug design, in addition to this new analysis of multi-drug combinations. Liao believes that technology will have an even bigger role to play going forward.
“In medicine, machine learning and artificial intelligence have not yet had as much impact as I believe they will in the future,” Liao said. “This project is a great example of how we can move toward truly personalized medicine.”
Reference: “Learning from real world data about combinatorial treatment selection for COVID-19” by Song Zhai, Zhiwei Zhang, Jiayu Liao and Xinping Cui, 3 April 2023, Frontiers in Artificial Intelligence.
DOI: 10.3389/frai.2023.1123285
![](https://www.nanoappsmedical.com/wp-content/uploads/2017/05/spacer.jpg)
News
Ethics in Nanomedicine: Key Issues and Principles
Nanomedicine, a branch of nanotechnology, is revolutionizing healthcare by enabling the manipulation of materials at the nanoscale to diagnose, treat, and prevent diseases. Unlike traditional treatments, nanoparticles (NPs) are highly precise in targeting diseased [...]
A call for robust H5N1 influenza preparedness and response
As the global threat of H5N1 influenza looms with outbreaks across species and continents including the U.S., three international vaccine and public health experts say it is time to fully resource and support a [...]
Mucosal COVID-19 boosters outperform mRNA shots in preventing upper airway infections
In a recent study published in Nature Immunology, a team of researchers from the United States used non-human primate models to compare the protection conferred by an intramuscular booster dose of the bivalent messenger ribonucleic acid [...]
How Space Travel Really Changes Astronauts – From the Inside Out
International team reveals previously unknown effects on physiology that could shape the future of long-duration space missions. Researchers have discovered significant changes in the gut microbiome due to spaceflight, which affects host physiology and [...]
Breakthrough in blood stem cell development offers hope for leukemia and bone marrow failure
Melbourne researchers have made a world first breakthrough into creating blood stem cells that closely resemble those in the human body. And the discovery could soon lead to personalized treatments for children with leukemia [...]
Scientists Develop Game-Changing Needle-Free COVID-19 Intranasal Vaccine
A new mucosal COVID-19 vaccine poised to revolutionize the delivery process is especially beneficial for those with a fear of needles. A next-generation COVID-19 mucosal vaccine is set to be a game-changer not only when delivering [...]
Scientists Develop All-in-One Solution To Catch and Destroy “Forever Chemicals”
A new water treatment system developed by UBC researchers efficiently removes and destroys PFAS pollutants using a dual-action catalyst, offering a sustainable and cost-effective solution for water purification challenges. Chemical engineers at the University of [...]
New method accelerates drug discovery from years to months
Researchers from the University of Cincinnati College of Medicine and Cincinnati Children's Hospital have found a new method to increase both speed and success rates in drug discovery. The study, published Aug. 30 in [...]
A new smart mask analyzes your breath to monitor your health
Your breath can give away a lot about you. Each exhalation contains all sorts of compounds, including possible biomarkers for disease or lung conditions, that could give doctors a valuable insight into your health. [...]
Study reveals the role of blood clotting in COVID-19
In a study that reshapes what we know about COVID-19 and its most perplexing symptoms, scientists have discovered that the blood coagulation protein fibrin causes the unusual clotting and inflammation that have become hallmarks [...]
A Novel Cancer Vaccine Combining Nano-11 and ADU-S100
In a recent article published in npj Vaccines, researchers detailed the development of a novel cancer vaccine that combines a plant-derived nanoparticle adjuvant, Nano-11, with a clinically tested STING agonist, ADU-S100. The primary objective was [...]
AI spots cancer and viral infections with nanoscale precision
Researchers have developed an artificial intelligence which can differentiate cancer cells from normal cells, as well as detect the very early stages of viral infection inside cells. The findings, published today in a study [...]
Tiny shards of plastic are increasingly infiltrating our brains, study says
Human brain samples collected at autopsy in early 2024 contained more tiny shards of plastic than samples collected eight years prior, according to a preprint posted online in May. A preprint is a study which has not yet [...]
Scientists Have Discovered Strange DNA in Our Brains – and It Could Be Shortening Our Lives
According to the research, these mitochondrial DNA insertions could be linked to early death. Mitochondria in brain cells frequently insert their DNA into the nucleus, potentially impacting lifespan, as those with more insertions were found to [...]
Watch Out After a Hospital Stay: You Could Be Exposing Your Family to Superbugs
Research indicates hospitals contribute to the local spread of antibiotic-resistant infections. A recent study published in the journal Infection Control & Hospital Epidemiology by the Society for Healthcare Epidemiology of America suggests that family members of [...]
Molecular Trickery: How COVID-19 Silently Sabotages the Human Immune System
Researchers have discovered that SARS-CoV-2 manipulates the human immune system by forcing cells to produce non-functional proteins, hindering the body’s antiviral defenses. This groundbreaking study by teams from prestigious Brazilian universities highlights potential targets for new COVID-19 treatments, [...]